These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10836350)

  • 1. Isosorbide-5-mononitrate in the treatment of pulmonary hypertension associated with portal hypertension.
    Ribas J; Angrill J; Barberà JA; García-Pagán JC; Roca J; Bosch J; Rodriguez-Roisin R
    Eur Respir J; 1999 Jan; 13(1):210-2. PubMed ID: 10836350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
    Ricci GL; Melgosa MT; Burgos F; Valera JL; Pizarro S; Roca J; Rodriguez-Roisin R; Barberà JA
    Liver Transpl; 2007 Nov; 13(11):1506-14. PubMed ID: 17969197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
    Piscaglia F; Donati G; Gaiani S; Gramantieri L; Leoni S; Mancini M; Bolondi L
    Dig Liver Dis; 2004 Sep; 36(9):594-602. PubMed ID: 15460844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
    Bolognesi M; Sacerdoti D; Merkel C; Gatta A
    J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
    Merkel C; Sacerdoti D; Bolognesi M; Bombonato G; Gatta A
    J Hepatol; 1998 Apr; 28(4):622-30. PubMed ID: 9566831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC; Westaby D; Williams R
    Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M; Chesta J; Bosch J; Rodés J
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical vs haemodynamic response to drugs in portal hypertension.
    McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
    J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
    Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term reduction of pulmonary hypertension in interstitial lung fibrosis by isosorbide dinitrate.
    Jezek V; Jezková J; Michaljanic A; Fucik J
    Eur Heart J; 1988 Jan; 9 Suppl A():213-7. PubMed ID: 3409916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.